USPTO 2015–2025 USPTO PatentsView US Corporation

Exabeam, Inc.

USPTO PatentsView assignee record - 21 granted patents across 5 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04L (Transmission OF Digital Information, e.g. Telegraphic Communication).

RSS updates for this company

The verdict

According to USPTO PatentsView, Exabeam ranks #13,979 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 5 technology areas.

#13,979
of 49,997 US assignees by volume
48th percentile
by Innovation Score (34.6/100)
20.0
avg claims per patent
+117%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13979 · US Corporation #13,979 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 21 grants
  • MID-PACK #13,979/49,997
  • PHOTO-FINISH EpiVax
  • CPC-NARROW H04L · 5 areas
  • INNOV-THIN 34.6/100
  • CLAIMS-DENSE 20.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +117% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: EpiVax Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Exabeam’s 34.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Exabeam

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Exabeam's Innovation Score is 34.6/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Exabeam?

Each dot is one of Exabeam’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Exabeam’s own 20.0 claims/patent is ABOVE the 18.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Exabeam vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 20.920.92121.1 01020304050 Granted patents (volume) Avg claims / patent EpiVax Inc. - 21, 12.95EpivaxErber AG - 21, 8.67ErberEtaGen, Inc. - 21, 25.29EtagenEvonik Oxeno GmbH & Co. KG - 21, 16.29Evonik Oxeno & KGExcelitas Canada, Inc. - 21, 20.86Excelitas CanadaExegy Incorporated - 21, 40.48Exegy IncorporatedEyePoint Pharmaceuticals, Inc. - 21, 18.9Eyepoint Pharmace…Eyenovia, Inc. - 21, 20.24EyenoviaExabeam, Inc. - 21, 20Exabeam
Exabeam vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Exabeam's grants concentrate

Exabeam, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 95.2% of grants classified under H04L (Transmission OF Digital Information, e.g. Telegraphic Communication). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2018. By volume, Exabeam sits between EpiVax Inc. and Eyenovia, Inc..

Exabeam's three-year grant acceleration

Exabeam, Inc. shows 6 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Exabeam's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Exabeam holds 21 patents at rank #13,979, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Exabeam

By rank, the assignees closest to #13,979 in granted patent volume.

Leaders in H04L (Transmission OF Digital Information)

Other assignees with the most granted patents in Exabeam's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Exabeam, neither rank-band nor same-CPC leaders (those blocks stay above). In H04L (Transmission OF Digital Information), Exabeam ranks #1,367 of 8,956 assignees by patent count in that subclass.

Exabeam's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201720182019202020212022202320242025 2
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Exabeam, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 9.5%
2018 1 4.8%
2019 3 14.3%
2020 3 14.3%
2021 4 19.0%
2022 2 9.5%
2023 1 4.8%
2024 3 14.3%
2025partial year 2 9.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Exabeam, Inc.'s patent record in context - here's where to go next.

  • Exabeam, Inc.'s lead technology class is H04L (Transmission OF Digital Information, e.g. Telegraphic Communication), 95.2% of its portfolio - see every assignee active in that class. Explore H04L
  • Ranked #13,979 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Exabeam, Inc. against EpiVax Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 34.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.